(0.28%) 5 169.25 points
(0.23%) 38 921 points
(0.26%) 18 048 points
(1.08%) $78.95
(0.70%) $2.16
(0.90%) $2 329.30
(2.66%) $27.40
(1.13%) $976.25
(-0.04%) $0.928
(-0.24%) $10.85
(-0.24%) $0.795
(0.00%) $91.45
3 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 10.33%
4.39% $ 5.47
Live Chart Being Loaded With Signals
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders...
Stats | |
---|---|
Dzisiejszy wolumen | 259 837 |
Średni wolumen | 333 425 |
Kapitalizacja rynkowa | 172.32M |
EPS | $0 ( 2024-02-29 ) |
Następna data zysków | ( $-0.110 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.59 |
ATR14 | $0.0130 (0.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-23 | Collier Earl M Jr | Buy | 30 000 | Common Stock |
2024-04-23 | Collier Earl M Jr | Sell | 30 000 | Stock Option (Right to Buy) |
2024-04-23 | Musket David B | Buy | 16 156 | Common Stock |
2024-04-23 | Musket David B | Sell | 5 750 | Stock Option (Right to Buy) |
2024-01-02 | Kelliher Mike | Buy | 30 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
79.05 |
Last 97 transactions |
Buy: 2 824 525 | Sell: 392 146 |
Wolumen Korelacja
Capricor Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
RPAY | 0.913 |
COIN | 0.906 |
LZ | 0.903 |
DAX | 0.902 |
SUPN | 0.9 |
IBUY | 0.897 |
GRMN | 0.892 |
OPRA | 0.891 |
GLSI | 0.89 |
MSTR | 0.889 |
10 Najbardziej negatywne korelacje | |
---|---|
BOWX | -0.869 |
WAVS | -0.859 |
METX | -0.85 |
SOFO | -0.837 |
NERV | -0.829 |
LMST | -0.823 |
NVEI | -0.82 |
ASRVP | -0.819 |
VERO | -0.816 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Capricor Therapeutics Inc Korelacja - Waluta/Towar
Capricor Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $25.18M |
Zysk brutto: | $24.11M (95.75 %) |
EPS: | $-0.830 |
FY | 2023 |
Przychody: | $25.18M |
Zysk brutto: | $24.11M (95.75 %) |
EPS: | $-0.830 |
FY | 2022 |
Przychody: | $2.55M |
Zysk brutto: | $1.85M (72.74 %) |
EPS: | $-1.180 |
FY | 2021 |
Przychody: | $245.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.000867 |
Financial Reports:
No articles found.
Capricor Therapeutics Inc
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with SARS-CoV-2. The company also develops CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in development stage for the potential prevention of COVID-19. It collaborates with Lonza Houston, Inc. for the clinical manufacturing of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in San Diego, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej